Geranylgeraniol Prevents Zoledronic Acid-mediated Reduction of Viable Mesenchymal Stem Cells Via Induction of Rho-dependent YAP Activation

Overview

Journal R Soc Open Sci

Specialty Science

Date 2021 Jun 11

PMID 34113452

Citations 7

Authors

Weerachai Singhatanadgit

Weerawan Hankamolsiri

Wanida Janvikul

Affiliations

Soon will be listed here.

Abstract

Long-term use of zoledronic acid (ZA) increases the risk of medication-related osteonecrosis of the jaw (MRONJ). This may be attributed to ZA-mediated reduction of viable mesenchymal stem cells (MSCs). ZA inhibits protein geranylgeranylation, thus suppressing cell viability and proliferation. Geranylgeraniol (GGOH), which is a naturally found intermediate compound in the mevalonate pathway, has positive effects against ZA. However, precise mechanisms by which GGOH may help preserve stem cell viability against ZA are not fully understood. The objective of this study was to investigate the cytoprotective mechanisms of GGOH against ZA. The results showed that while ZA dramatically decreased the number of viable MSCs, GGOH prevented this negative effect. GGOH-rescued ZA-exposed MSCs formed mineralization comparable to that produced by normal MSCs. Mechanistically, GGOH preserved the number of viable MSCs by its reversal of ZA-mediated Ki67 MSC number reduction, cell cycle arrest and apoptosis. Moreover, GGOH prevented ZA-suppressed RhoA activity and YAP activation. The results also established the involvement of Rho-dependent YAP and YAP-mediated CDK6 in the cytoprotective ability of GGOH against ZA. In conclusion, GGOH preserves a pool of viable MSCs with osteogenic potency against ZA by rescuing the activity of Rho-dependent YAP activation, suggesting GGOH as a promising agent and YAP as a potential therapeutic target for MRONJ.

Citing Articles

Cystatin M/E Ameliorates Multiple Myeloma-Induced Hyper Osteolytic Bone Resorption.

Gai D, Caviness P, Lazarenko O, Chen J, Randolph C, Zhang Z Cancers (Basel). 2025; 17(5).

PMID: 40075680 PMC: 11899016. DOI: 10.3390/cancers17050833.

Cystatin M/E ameliorates bone resorption through increasing osteoclastic cell estrogen influx.

Gai D, Caviness P, Lazarenko O, Chen J, Randolph C, Zhang Z Res Sq. 2024; .

PMID: 38766009 PMC: 11100902. DOI: 10.21203/rs.3.rs-4313179/v1.

YAP/TAZ: Molecular pathway and disease therapy.

Wei Y, Lee Zhi Hui V, Chen Y, Han R, Han X, Guo Y MedComm (2020). 2023; 4(4):e340.

PMID: 37576865 PMC: 10412783. DOI: 10.1002/mco2.340.

Dual-Functional Drug Delivery System for Bisphosphonate-Related Osteonecrosis Prevention and Its Bioinspired Releasing Model and In Vitro Assessment.

Sungkhaphan P, Thavornyutikarn B, Muangsanit P, Kaewkong P, Kitpakornsanti S, Pornsuwan S ACS Omega. 2023; 8(29):26561-26576.

PMID: 37521598 PMC: 10373185. DOI: 10.1021/acsomega.3c03440.

Effect of Dietary Geranylgeraniol and Green Tea Polyphenols on Glucose Homeostasis, Bone Turnover Biomarkers, and Bone Microstructure in Obese Mice.

Shen C, Dufour J, Miranda J, Kaur G, Chung E, Ramalingam L Int J Mol Sci. 2023; 24(2).

PMID: 36674494 PMC: 9866936. DOI: 10.3390/ijms24020979.

References

Levy M, Parker R, Ferrell R, Zmuda J, Greenspan S . Farnesyl diphosphate synthase: a novel genotype association with bone mineral density in elderly women. Maturitas. 2007; 57(3):247-52. PMC: 1951796. DOI: 10.1016/j.maturitas.2007.01.005. View

Vaisman D, McCarthy A, Cortizo A . Bone-specific alkaline phosphatase activity is inhibited by bisphosphonates: role of divalent cations. Biol Trace Elem Res. 2005; 104(2):131-40. DOI: 10.1385/BTER:104:2:131. View

Kegelman C, Mason D, Dawahare J, Horan D, Vigil G, Howard S . Skeletal cell YAP and TAZ combinatorially promote bone development. FASEB J. 2018; 32(5):2706-2721. PMC: 5901392. DOI: 10.1096/fj.201700872R. View

Stamatakis K, Cernuda-Morollon E, Hernandez-Perera O, Perez-Sala D . Isoprenylation of RhoB is necessary for its degradation. A novel determinant in the complex regulation of RhoB expression by the mevalonate pathway. J Biol Chem. 2002; 277(51):49389-96. DOI: 10.1074/jbc.M204049200. View

Ziebart T, Pabst A, Klein M, Kammerer P, Gauss L, Brullmann D . Bisphosphonates: restrictions for vasculogenesis and angiogenesis: inhibition of cell function of endothelial progenitor cells and mature endothelial cells in vitro. Clin Oral Investig. 2009; 15(1):105-11. DOI: 10.1007/s00784-009-0365-2. View

Totaro A, Panciera T, Piccolo S . YAP/TAZ upstream signals and downstream responses. Nat Cell Biol. 2018; 20(8):888-899. PMC: 6186418. DOI: 10.1038/s41556-018-0142-z. View

Maeda T, Chong M, Espino R, Chua P, Cao J, Chomey E . Role of p21(Waf-1) in regulating the G1 and G2/M checkpoints in ultraviolet-irradiated keratinocytes. J Invest Dermatol. 2002; 119(2):513-21. DOI: 10.1046/j.1523-1747.2002.01828.x. View

Xiong J, Almeida M, OBrien C . The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation. Bone. 2018; 112:1-9. PMC: 5970058. DOI: 10.1016/j.bone.2018.04.001. View

Ruggiero S, Dodson T, Fantasia J, Goodday R, Aghaloo T, Mehrotra B . American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update. J Oral Maxillofac Surg. 2014; 72(10):1938-56. DOI: 10.1016/j.joms.2014.04.031. View

10.

Sato M, Grasser W, Endo N, Akins R, Simmons H, Thompson D . Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure. J Clin Invest. 1991; 88(6):2095-105. PMC: 295810. DOI: 10.1172/JCI115539. View

11.

Rollason V, Laverriere A, MacDonald L, Walsh T, Tramer M, Vogt-Ferrier N . Interventions for treating bisphosphonate-related osteonecrosis of the jaw (BRONJ). Cochrane Database Syst Rev. 2016; 2:CD008455. PMC: 7173706. DOI: 10.1002/14651858.CD008455.pub2. View

12.

Chung M, Liu C, Yang H, Koberlin M, Cappell S, Meyer T . Transient Hysteresis in CDK4/6 Activity Underlies Passage of the Restriction Point in G1. Mol Cell. 2019; 76(4):562-573.e4. PMC: 7189330. DOI: 10.1016/j.molcel.2019.08.020. View

13.

Yoshikawa N, Yamada J, Tsuno N, Okaji Y, Kawai K, Tsuchiya T . Plaunotol and geranylgeraniol induce caspase-mediated apoptosis in colon cancer. J Surg Res. 2008; 153(2):246-53. DOI: 10.1016/j.jss.2008.04.021. View

14.

Jorda R, Hendrychova D, Voller J, Reznickova E, Gucky T, Krystof V . How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?. J Med Chem. 2018; 61(20):9105-9120. DOI: 10.1021/acs.jmedchem.8b00049. View

15.

Scheper M, Badros A, Salama A, Warburton G, Cullen K, Weikel D . A novel bioassay model to determine clinically significant bisphosphonate levels. Support Care Cancer. 2009; 17(12):1553-7. DOI: 10.1007/s00520-009-0710-7. View

16.

Jia L, Gu W, Zhang Y, Jiang B, Qiao X, Wen Y . Activated Yes-Associated Protein Accelerates Cell Cycle, Inhibits Apoptosis, and Delays Senescence in Human Periodontal Ligament Stem Cells. Int J Med Sci. 2018; 15(11):1241-1250. PMC: 6097269. DOI: 10.7150/ijms.25115. View

17.

Viatour P . Bridges between Cell Cycle Regulation and Self-Renewal Maintenance. Genes Cancer. 2013; 3(11-12):670-7. PMC: 3636744. DOI: 10.1177/1947601913481355. View

18.

Patntirapong S, Singhatanadgit W, Chanruangvanit C, Lavanrattanakul K, Satravaha Y . Zoledronic acid suppresses mineralization through direct cytotoxicity and osteoblast differentiation inhibition. J Oral Pathol Med. 2012; 41(9):713-20. DOI: 10.1111/j.1600-0714.2012.01154.x. View

19.

Jung H, Yoon S, Lim J, Cho H, Lee H . Dysregulation of Rho GTPases in Human Cancers. Cancers (Basel). 2020; 12(5). PMC: 7281333. DOI: 10.3390/cancers12051179. View

20.

David M, Petit D, Bertoglio J . Cell cycle regulation of Rho signaling pathways. Cell Cycle. 2012; 11(16):3003-10. PMC: 3442911. DOI: 10.4161/cc.21088. View